Focus research 2022 RADOPT team
Metabolic shift & radioresistance
The MSrGB (Metabolic Shift in radioresistance of Glioblastoma) project, which is coordinated by Prof. Elizabeth Moyal and accredited by the Fondation ARC (PGA) in 2022, aims to study the involvement of metabolic shift in glioblastoma stem cells in adaptation and resistance to radiotherapy. In addition to the RADOPT team, this program involves the IUCT-Oncopole, as well as Prof. Tourneret’s team at IRIT, where new metabolites and their ability to predict relapse after treatment will be identified and studied using deep learning. To find out more
To find out more about the IUCT-Oncopole and CRCT-Oncopole research focuses, please click here.
Toulouse Cancer Research Center (Oncopole)
Toulouse - FR
CRCT-Oncopole Follow 1,433 1,279
Compte officiel du Centre de Recherches en Cancérologie de Toulouse
;
🇬🇧Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells. ImPact team @CordelierPierre article from @crctoncopole published in @CommsBio
➡️https://www.crct-inserm.fr/en/targeting-the-energy-production-process-in-pancreatic-cancer-cells-which-relies-on-an-enzyme-called-cytidine-deaminase-could-make-these-cells-more-vulnerable/
Contact us
+33 5 82 74 15 75
Want to join
the CRCT team ?
